Benzinga | Jan 27, 2021 01:17PM EST

JMP Securities Maintains Market Outperform on Zimmer Biomet Holdings, Raises Price Target to $180

JMP Securities analyst David Turkaly maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Outperform and raises the price target from $165 to $180.